tiprankstipranks
Forte Biosciences Inc. (FBRX)
NASDAQ:FBRX
US Market
FBRX
Forte Biosciences
RESEARCH TOOLSreports

Forte Biosciences (FBRX) Stock News & Sentiment

328 Followers
Forte Biosciences Prices $150 Million Public Offering
Premium
Company Announcements
Forte Biosciences Prices $150 Million Public Offering
7d ago
8K
FBRX
Is FBRX a Buy, Before Earnings?
Premium
Pre-Earnings
Is FBRX a Buy, Before Earnings?
25d ago
FBRX
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
Premium
Company Announcements
Forte Biosciences Reports Increased R&D Costs Amid Clinical Progress
5M ago
FBRX
Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment
Premium
Company Announcements
Forte Biosciences Inc. Launches Promising Study on Alopecia Areata Treatment
6M ago
FBRX
Forte Biosciences Advances Celiac Disease Treatment with FB102 Study
Premium
Company Announcements
Forte Biosciences Advances Celiac Disease Treatment with FB102 Study
6M ago
FBRX
Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment
Premium
Company Announcements
Forte Biosciences’ FB102 Study: A Potential Breakthrough in Vitiligo Treatment
6M ago
FBRX
Forte Biosciences Reports Q2 2025 Financial Results
Premium
Company Announcements
Forte Biosciences Reports Q2 2025 Financial Results
8M ago
FBRX
More FBRX News >

FBRX News on the Web

Forte Biosciences Prices $150 Million Public Offering
TipRanks News
Bearish
Forte Biosciences Announces $150 Million Public Offering at $26.27 per Share—What Does This Mean for the Pipeline and Investors?
Market Chameleon
Neutral
Forte Biosciences Raises $150 Million to Accelerate Autoimmune Research: What This Offering Means for FBRX
Market Chameleon
Neutral
Forte Biosciences 5.71M share Spot Secondary priced at $26.27
TipRanks News
Neutral
Forte Biosciences announces common stock offering, no amount given
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Tvardi Therapeutics (TVRD) and Forte Biosciences (FBRX)
TipRanks News
Neutral
Analysts Offer Insights on Healthcare Companies: Tarsus Pharmaceuticals (TARS) and Forte Biosciences (FBRX)
TipRanks News
Neutral
Forte Biosciences reports FY25 EPS ($4.71) vs. ($12.17) last year
TipRanks News
Bullish

News Score - Last 7 Days

Negative
FBRX
Sector Average
Media Buzz
This Week3 articles
Weekly Average2.25 articles
News Sentiment
This Week0%
Sector Average69%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is FBRX’s Media Buzz Sentiment?
3 articles about FBRX were published this week. In an average week, 2.25 articles are published.
    What is FBRX’s weekly average amount of articles?
    In an average week, 2.25 articles about FBRX are published.
      What is FBRX’s News Sentiment?
      Currently, no data Available
      Healthcare Stocks that are Trending in the News
      GLMDGalmed Pharmaceuticals
      ALLOAllogene Therapeutics
      TXTMProText Mobility
      REPLReplimune Group
      IVVDInvivyd
      Showing the stocks with the most bullish news sentiment over the past week